Sign In
Section Navigation
Common TitleWAND
Official Title An Open-label Study of the Tolerability of a Subcutaneous Needle-free Injection Device Used to Administer Fuzeon, Compared With the Standard Needle/Syringe Supplied With Commercial Fuzeon in HIV-1 Infected, ARV Treatment-experienced Adults
Phase Phase IV
ClinicalTrials.gov NCT00233883
Categories PharmacologyTreatment-ExperiencedAdverse Effects
Funding
IndustryHoffmann-La Roche
References
  • Gottlieb M, Thommes JA. Short communication safety, tolerability and pharmacokinetics of enfuvirtide administered by a needle-free injection system compared with subcutaneous injection. Antivir Ther. 2008;13:723-7.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.